West German Lymphoma Symposium

Following the inaugural West German Lymphoma Symposium in 2024, we are delighted to continue this exciting new tradition. The high level of scientific exchange during the first meeting confirmed the need for a dedicated regional and international forum focused on both preclinical and clinical lymphoma research.

preclinical and clinical lymphoma research continues to evolve rapidly, with major breakthroughs in the molecular understanding of the disease, the refinement of mouse models, and advances in preclinical drug development. These developments have led to significant changes in treatment strategies, including the integration of CAR-T cells, bispecific antibodies, and next-generation small molecules.

In parallel, the comprehensive cancer centers CIO-ABCD (Aachen, Bonn, Cologne, Düsseldorf) and WTZ-EM (Essen, Münster) in North Rhine-Westphalia have intensified their collaboration, notably through the establishment of the National Center for Tumor Diseases West (NCT-West, Essen and Cologne), fostering robust clinical and translational lymphoma programs and to excite young researchers for lymphoma research.

Building on this momentum, the second West German Lymphoma Symposium, aims to strengthen regional and international exchange, engage young scientists, and continue shaping the future of lymphoma research together.

Abstract submissions (Deadline: March 2nd) are warmly encouraged. Selected abstracts will be featured in short talks and considered for poster prizes.

Registration

More information about this event